Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Status:
Recruiting

Trial end date:
2023-09-01

Target enrollment:

Participant gender:

The purpose of the study is to evaluate the efficacy of treatment with abemaciclib in patients with anaplastic thyroid/undifferentiated thyroid

Phase 2

Stanford University